CD8A and cancer: Antigen presentation on MHC class I molecules is a key component of immunosurveillance, and cytotoxic CD8+ T cells can recognize altered cells through tumor antigens (such as neoantigens, human endogenous retroviral (HERV) antigens, tumor-associated antigens and cancer testis antigens (CTAs)) [299,300,301,302].